Does TOCILIZUMAB Cause Hepatic function abnormal? 460 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 460 reports of Hepatic function abnormal have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 0.5% of all adverse event reports for TOCILIZUMAB.
460
Reports of Hepatic function abnormal with TOCILIZUMAB
0.5%
of all TOCILIZUMAB reports
23
Deaths
76
Hospitalizations
How Dangerous Is Hepatic function abnormal From TOCILIZUMAB?
Of the 460 reports, 23 (5.0%) resulted in death, 76 (16.5%) required hospitalization, and 14 (3.0%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 460 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
Which TOCILIZUMAB Alternatives Have Lower Hepatic function abnormal Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE